Over 20 NHS trusts have ditched Palantir waiting-list tools, analysis shows
Over 20 NHS trusts have abandoned Palantir's waiting-list tools. Fresh regulator probe into health-service claims on the controversial data project.
Why it matters
A material healthcare deployment reversal raises operational and governance questions about AI tool adoption in regulated environments. The regulator scrutiny signals risk for vendors claiming AI-driven health outcomes without independent validation.
The key facts
5 to knowOver 20 NHS trusts ditched Palantir waiting-list tools
Financial Times analysis prompted fresh statistics regulator investigation
Palantir made claims about health-service data project that regulator is now probing
Deployment reversal indicates potential mismatch between vendor claims and operational reality
UK healthcare system impact — NHS is major regulated buyer
Go to the source
Financial Times Technologyft.com
Publisher excerpt: FT findings prompt fresh probe by statistics regulator into health service claims over controversial data project